Centralna sp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2003-02-21
Share capital
1,550,000.00 PLN
Registered address
ul. Kinga C. Gillette 11, 94-406 Łódź, Poland
Electronic delivery address
AE:PL-95179-33794-GDIEH-19

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 13 days late).

  • 202510/05/2026
  • 202402/07/2025
  • 202314/05/2024
  • 202223/06/2023
  • 202128/07/2022
  • 202001/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 31%
Division · Retail trade2,219 / 9,987
Top 22%
City · Łódź791 / 8,057
Top 9.8%
Voivodeship · Łódzkie1,935 / 15,323
Top 13%
Country · Poland35,823 / 297,069
Top 12%

Results vs industry

Revenue
This companyUSD 4.52mMedianUSD 1.92mAverageUSD 5.21m
Net profit
This companyUSD 232.31kMedianUSD 21.16kAverageUSD 85.84k
Operating costs
This companyUSD 4.22mMedianUSD 1.88mAverageUSD 5.06m
Assets
This companyUSD 1.64mMedianUSD 545.50kAverageUSD 1.76m

National Health Fund (NFZ) contracts

The company has been an NFZ healthcare provider since 2019. In 2026 it is performing 2 contracts with a total value of USD 81.04. All its contracts were worth USD 1.15k in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Pilot programmesłódzkie1USD 81.04
Other services provided in pharmaciesłódzkie1USD 0.00

Authorized Representatives

Aleksandra Olszacka age 50 – Vice President of the Management Board
Bożena Helena Szymańska age 75 – President of the Management Board
Katarzyna Ewa Nockowska-Stańczak age 51 – Vice President of the Management Board

Manner of representation

In the event that a multi-member management board is appointed, two members of the management board acting jointly or one member of the management board acting together with a commercial proxy are authorised for declarations made on behalf of the company to be valid.

Ownership

OwnerSharesShare valueStake
7,440$100,486.2224%
23,560$318,206.3776%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2000-10-10.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,213
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,708
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,613

Competitors

Name
Fragal sp. z o.o.
Modrzewscy sp. j.
Ms-Pharm sp. z o.o. + limited partnership
Farmjug Ag sp. z o.o.
Magmax S.A.
Adpharma sp. z o.o.
Alfa Pharm - Małgorzata Janusik, Jarosław Janusik sp. j.
Novopharm - Miller sp. j.
Pikada sp. z o.o.
Awicenna sp. j.

Change history

DateEvent
2024-12-02Address change
2015-07-20PKD change
2010-02-26Switch to PKD 2007
2008-02-11Share capital increase
2006-07-31Share capital increase

FAQ

Last updated: 2026-05-10